- About Us
- Studies for Risk Management
- Consulting on Risk Management
- Other Research Services
- Public Health
- Study Recruitment
The Drug Safety Research Unit (DSRU) is an independent academic unit internationally respected for its work in Pharmacovigilance, Pharmacoepidemiology, Risk Management and Training for over 30 years.
In partnership with doctors in England, the DSRU, led by Director Professor Saad Shakir, aims to protect patients in primary and specialist care from unwanted adverse effects of newly marketed medicines using our unique methods of monitoring patients during the lifecycle of medicines.
DSRU scientists, Rhian McNaughton, Gwenaël Huet and Saad Shakir have recently published a paper in the open access journal BMJ Open entitled, ”An investigation into drug products withdrawn from the EU market between 2002 and 2011 for safety reasons and the evidence used to support the decision making". This research concluded that there was a marked shift towards the utilisation of results from randomized controlled trials, case-control studies, cohort studies and meta-analyses in conjunction with spontaneous case reports to aid in the decision making to withdraw drugs from the entire EU market for safety concerns between 2002 and 2011.View our latest news